Amal Ali Elkordy
Overview
Explore the profile of Amal Ali Elkordy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elkordy A, Hill D, Attia M, Chaw C
Nanomaterials (Basel)
. 2024 Nov;
14(21).
PMID: 39513840
Psoriasis and breast cancer are two examples of diseases where associated inflammatory pathways within the body's immune system are implicated. Psoriasis is a complex, chronic and incurable inflammatory skin disorder...
2.
Alam M, Paget T, Yussuf Moosa N, Alghurairy H, Elkordy A
Pharmaceutics
. 2024 Sep;
16(9).
PMID: 39339161
() infection is a significant global health concern, affecting approximately 50% of the world's population and leading to gastric ulcers, gastritis, and gastric cancer. The increase in antibiotic resistance has...
3.
Parveen A, Elkordy A
Pathogens
. 2024 Jun;
13(6).
PMID: 38921798
A mRNA vaccine is a type of vaccine that induces an immune response. Antigen-encoding mRNA is delivered via vaccine carriers into the immune cells, which are produced because of antigen-encoding...
4.
Al Badri Y, Chaw C, Elkordy A
Pharmaceutics
. 2023 Jan;
15(1).
PMID: 36678922
Liposome-based drug delivery systems are nanosized spherical lipid bilayer carriers that can encapsulate a broad range of small drug molecules (hydrophilic and hydrophobic drugs) and large drug molecules (peptides, proteins,...
5.
Attia M, Essa E, Elebyary T, Faheem A, Elkordy A
Pharmaceuticals (Basel)
. 2021 Nov;
14(11).
PMID: 34832955
Vaccination is the most effective means of preventing infectious diseases and saving lives. Modern biotechnology largely enabled vaccine development. In the meantime, recent advances in pharmaceutical technology have resulted in...
6.
Arshad M, Zafar S, Yousef B, Alyassin Y, Ali R, Alasiri A, et al.
Adv Drug Deliv Rev
. 2021 Jun;
178:113840.
PMID: 34147533
Tablets are the most widely utilized solid oral dosage forms because of the advantages of self-administration, stability, ease of handling, transportation, and good patient compliance. Over time, extensive advances have...
7.
Attia M, Essa E, Zaki R, Elkordy A
Antioxidants (Basel)
. 2020 Apr;
9(5).
PMID: 32344912
Antioxidants are known to minimize oxidative stress by interacting with free radicals produced as a result of cell aerobic reactions. Oxidative stress has long been linked to many diseases, especially...
8.
Elsana H, Olusanya T, Carr-Wilkinson J, Darby S, Faheem A, Elkordy A
Sci Rep
. 2019 Oct;
9(1):15120.
PMID: 31641141
In gene delivery, non-viral vectors have become the preferred carrier system for DNA delivery. They can overcome major viral issues such as immunogenicity and mutagenicity. Cationic lipid-mediated gene transfer is...
9.
Yeo L, Chaw C, Elkordy A
Pharmaceuticals (Basel)
. 2019 Apr;
12(2).
PMID: 30934834
This work aimed to investigate and optimise the effects of co-surfactants, hydration volume, and time on the entrapment of methylene blue (MB) within niosomes and the vesicle sizes of MB-loaded...
10.
Yeo L, Olusanya T, Chaw C, Elkordy A
Pharmaceutics
. 2018 Oct;
10(4).
PMID: 30322124
Novel niosomal formulations containing cinnarizine were developed to enhance its drug characteristics. In this work, niosomes (non-ionic surfactant vesicles) were prepared by conventional thin-film hydration (TFH) and microfluidic (MF) methods...